Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction and Reduced Dose Radiation in Head and Neck Cancer
NCT00352118Phase 2Terminated
- Sponsor
- Masonic Cancer Center
- Start
- Mar 2006
- Primary completion
- Apr 2008
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by Masonic Cancer Center. Started Mar 2006; status: terminated.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00352118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352118.